Johnson & Johnson8-K: Succession announcementOct 13, 2026

Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Replacing Retiring Jennifer Taubert

Read at SEC EDGAR

What happened

Taubert's retirement brings new leadership overseeing more than $16 billion in quarterly pharmaceutical sales.

Source

SEC EDGAROct 13, 2026

Current report (Form 8-K)

Johnson & Johnson 8-K

Filing excerpt

Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

sec.gov/Archives/edgar/data/200406/000020040626000189/jnj-20261013.htmRead the full source

Other signals in this filing (4)

Restructuring chargeJohnson & Johnson Incurs $181M Q3 Restructuring Charge as Part of $650M-$750M Supply Chain OptimizationRestructuring chargeOct 13, 2026
RestructuringJ&J Initiates $650M-$750M Supply Chain Restructuring Exiting Manufacturing Sites Through 2029RestructuringOct 13, 2026
Acquisition completedJohnson & Johnson Completes Acquisition of Firefly Bio to Expand Oncology PipelineAcquisition completedOct 13, 2026
Product launchFDA Grants Market Authorization for OTTAVA Soft Tissue Robotic Surgical SystemProduct launchOct 13, 2026

Extracted by Autobound

From the Signal API record

Signal: 8-K: Succession announcement

What this signalsFilings often name leadership changes, deals and spending plans.

Form: 8-K
Fiscal year end: 10/13
Filed: Oct 13, 2026

More 8-K signals at other companies

SEC 8-KAAR Corp.AAR Corp. amends credit facility to permit pending acquisition of MRO HoldingsSEC 8-KOct 26, 2026
SEC 8-KBlue Ridge Bankshares, Inc.Blue Ridge Bankshares announced definitive merger agreement with HomeTrust Bancshares anticipated closing Q1 2027SEC 8-KOct 26, 2026
SEC 8-KBoston Omaha CorporationBoston Omaha Completes $84.3M Sale of Surety Insurance Business Unit GIGSEC 8-KOct 26, 2026

The full record

From the Signal API record

Details

CIK: 200406
Accession number: 0000200406-26-000189
Timeframe: Immediate
Filing year: 2026
Why it matters: Upcoming vendor review window
Signal category: Leadership

Topics and mentions

Regions named

Worldwide

Extraction

Confidence: High
Relevance: 95%
Sentiment: Neutral
Detected: Oct 20, 2026
signal_type: sec-8k
signal_subtype: successionAnnouncement

Use this data

Get every 8-K signal for Johnson & Johnson and the companies you sell to, in the tools you already use.

Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”
MCP setup guide
Send it to your own tools
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Signal API
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

linkedin_urlValue in the API
industriesValue in the API
employee_count_lowValue in the API
employee_count_highValue in the API
revenueValue in the API
descriptionValue in the API

Signal

signal_nameValue in the API
associationValue in the API

Start Free1,000 free creditsUse it in Claude via MCP

Show the full JSONThe record on this page and the API request

GET /v1/signals/a5cd5649-97aa-4f05-9856-3324490b46f4 returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.

{
  "signal_id": "a5cd5649-97aa-4f05-9856-3324490b46f4",
  "signal_type": "sec-8k",
  "signal_subtype": "successionAnnouncement",
  "detected_at": "2026-10-20T07:04:03.335+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "detail": "Executive transition atop Johnson & Johnson's largest segment creates an immediate 90-day window for strategic evaluation of enterprise vendors and commercial partners. Taubert's retirement brings new leadership overseeing more than $16 billion in quarterly pharmaceutical sales.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Replacing Retiring Jennifer Taubert",
    "excerpts": "Johnson’s Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September",
    "relevance": 0.95,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000189/jnj-20261013.htm",
    "filing_date": "2026-10-13",
    "filing_year": 2026,
    "fiscal_year_end": "10/13",
    "sales_relevance": "Upcoming vendor review window",
    "signal_category": "leadership",
    "regions_mentioned": [
      "Worldwide"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/a5cd5649-97aa-4f05-9856-3324490b46f4 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"jnj.com","limit":20}'

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.